Identification of polymorphisms in the XIAP gene and analysis of association with lung cancer risk in a Korean population

Cancer Genetics and Cytogenetics

Volumn 180, Issue 1, 2008, Pages 6-13

  Kang, Hyo Gyoung ^a   Lee, Su Jeong ^a   Chae, Myung Hwa ^a   Lee, Won Kee ^a   Cha, Sung Ick ^b   Kim, Chang Ho ^b   Kam, Sin ^a   Park, Rang Woon ^a   Kim, In San ^a   Kim, Dong Sun ^a   Kim, Young Chul ^c   Jung, Tae Hoon ^b   Park, Jae Yong ^a,b  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

^c Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; X LINKED INHIBITOR OF APOPTOSIS;

ADENOCARCINOMA; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENETIC LINKAGE; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; KOREA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

MAMMALIA;

EID: 36549034323     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.07.021     Document Type: Article

References (30)

1. Shields P.G., and Harris C.C. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 18 (2000) 2309-2315
2. Raff M. Cell suicide for beginners. Nature 396 (1998) 119-122
3. Shivapurkar N., Reddy J., Chaudhary P.M., and Gazdar A.F. Apoptosis and lung cancer: a review. J Cell Biochem 88 (2003) 885-898
4. Hajra K.M., and Liu J.R. Apoptosome dysfunction in human cancer. Apoptosis 9 (2004) 691-704
5. Degterev A., Boyce M., and Yuan J. A decade of caspases. Oncogene 22 (2003) 8543-8567
6. Delhalle S., Duvoix A., Schnekenburger M., Morceau F., Dicato M., and Diederich M. An introduction of the molecular mechanisms of apoptosis. Ann N Y Acad Sci 1010 (2003) 1-8
7. Salvesen G.S., and Duckett C.S. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3 (2002) 401-410
8. Schimmer A.D. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 64 (2004) 7183-7190
9. Liston P., Roy N., Tamai K., Lefebvre C., Baird S., Cherton-Horvat G., Farahani R., McLean M., Ikeda J.E., MacKenzie A., and Korneluk R.G. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379 (1996) 349-353
10. Salvesen G.S., and Duckett C.S. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3 (2002) 401-410
11. Tamm I., Kornblau S.M., Segall H., Krajewski S., Welsh K., Kitada S., Scudiero D.A., Tudor G., Qui Y.H., Monks A., Andreeff M., and Reed J.C. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 6 (2000) 1796-1803
12. Ferreira C.G., van der Valk P., Span S.W., Jonker J.M., Postmus P.E., Kruyt F.A., and Giaccone G. Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients. Ann Oncol 12 (2001) 799-805
13. Hofmann H.S., Simm A., Hammer A., Silber R.E., and Bartling B. Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer. J Cancer Res Clin Oncol 128 (2002) 554-560
14. Ferreira C.G., van der Valk P., Span S.W., Ludwig I., Smit E.F., Kruyt F.A., Pinedo H.M., van Tinteren H., and Giaccone G. Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients. Clin Cancer Res 7 (2001) 2468-2474
15. Hu Y., Cherton-Horvat G., Dragowska V., Baird S., Korneluk R.G., Durkin J.P., Mayer L.D., and LaCasse E.C. Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. Clin Cancer Res 9 (2003) 2826-2836
16. Spitz M.R., Wei Q., Dong Q., Amos C.I., and Wu X. Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev 12 (2003) 689-698
17. Sun T., Miao X., Zhang X., Tan W., Xiong P., and Lin D. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst 96 (2004) 1030-1036
18. Park J.Y., Park J.M., Jang J.S., Choi J.E., Kim K.M., Cha S.I., Kim C.H., Kang Y.M., Lee W.K., Kam S., Park R.W., Kim I.S., Lee J.T., and Jung T.H. Caspase 9 promoter polymorphisms and risk of primary lung cancer. Hum Mol Genet 15 (2006) 1963-1971
19. Park J.M., Choi J.E., Chae M.H., Lee W.K., Cha S.I., Son J.W., Kim C.H., Kam S., Kang Y.M., Jung T.H., and Park J.Y. Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study. BMC Cancer 6 (2006) 70
20. Parks S.B., Popovich B.W., and Press R.D. Real-time polymerase chain reaction with fluorescent hybridization probes for the detection of prevalent mutations causing common thrombophilic and iron overload phenotypes. Am J Clin Pathol 115 (2001) 439-447
21. Stephens M., Smith M.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
22. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., and Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70 (2002) 425-434
23. MacPherson G., Healey C.S., Teare M.D., Balasubramanian S.P., Reed M.W., Pharoah P.D., Ponder B.A., Meuth M., Bhattacharyya N.P., and Cox A. Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 96 (2004) 1866-1869
24. Son J.W., Kang H.K., Chae M.H., Choi J.E., Park J.M., Lee W.K., Kim C.H., Kim D.S., Kam S., Kang Y.M., and Park J.Y. Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genet Cytogenet 169 (2006) 121-127
25. Imyanitov E., Hanson K., and Zhivotovsky B. Polymorphic variations in apoptotic genes and cancer predisposition. Cell Death Diff 12 (2005) 1004-1007
26. Rigaud S., Fondanèche M.C., Lambert N., Pasquier B., Mateo V., Soulas P., Galicier L., Le Deist F., Rieux-Laucat F., Revy P., Fischer A., de Saint Basile G., and Latour S. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444 (2006) 110-114
27. Wagenleiter S.E.N., Jagiello P., Akkad D.A., Arning L., Griga T., Klein W., and Epplen J.T. On the genetic involvement of apoptosis-related genes in Crohn's disease as revealed by an extended association screen using 245 markers: no evidence for new predisposing factors. J Negative Results BioMed 4 (2005) 8
28. Holcik M., Lefebvre C., Yeh C., Chow T., and Korneluk R.G. A new internal-ribosomal-entry-site motif potentiates XIAP-mediated cytoprotection. Nat Cell Biol 1 (1999) 190-192
29. Holcik M., Graber T., Lewis S.M., Lefebvre C.A., Lacasse E., and Baird S. Spurious splicing within the XIAP 5′ UTR occurs in the Rluc/Fluc but not βgal/CAT bicistronic reporter system. RNA 11 (2005) 1605-1609
30. Baird S.D., Turcotte M., Korneluk R.G., and Holcik M. Searching for IRES. RNA 12 (2006) 1755-1785